Covid 19 Variant Makes Up For 11% Of All Cases, New Report Says

Covid 19 Variant Makes Up For 11% Of All Cases, New Report Says

It seems that a new covid variant is making up for 11% of all the cases out there. Check out more details about these latest reports below.

It’s been just revealed that the Centers for Disease Control and Prevention said Tuesday that the BA.2 subvariant is responsible for about 1-in-10 covid 19 cases in the country, according to Reuters.

That number represents a 5% increase from the previous week, per U.S. News and World Report.
The World Health Organization said the BA.2 has been spreading fast globally, too, according to the same official reports. 

Deseret News also noted the fact that Spokane Regional Health District Health Officer Francisco Velazquez told KREM 2 News that the BA.2 covid variant spreads faster than omicron and leads to symptoms such as dizziness and fatigue.

Source: Pixabay
Source: Pixabay

Velazquez also made sure to highlight the fact that some people worried about catching the BA.2 subvariant should be fully vaccinated against covid 19. 

“Scientists have some evidence that the BA.2 subvariant of the omicron coronavirus variant can cause severe COVID-19 symptoms compared to the original omicron, according to recent lab experiments in Japan.”

Covid treatment can cause drug-resistant mutation 

Earlier today, we revealed that the Australian virologists have uncovered a drug-resistant mutation in the Covid-19 virus associated with the drug sotrovimab.

They also made sure to say that without the monitoring of patients given the treatment the mutated virus could spread in the community.

The world-first findings were published in the New England Journal of Medicine on Thursday. It’s also important to mention the fact that these are the result of an analysis of the first 100 patients in western Sydney during the Delta outbreak in 2021 to be given sotrovimab.

According to the official reports, sotrovimab is a monoclonal antibody that is available in many countries to treat vulnerable patients who are at risk of severe disease and death due to Covid-19 infection.

Check out our previous article in order to learn more details about the subject. 

Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.